Back | Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
Thats the difference between swing/traders vs long term | den4 | investorshub | 07/01/2024 4:57:13 PM |
SOrry | BBANBOB | investorshub | 07/01/2024 4:52:53 PM |
I'm in awe of the continued selling its | lovethatgreen | investorshub | 07/01/2024 4:50:59 PM |
Yes me too, because of this.. https://www.nasdaq.com/press-release/radiogel-pre | den4 | investorshub | 07/01/2024 4:40:19 PM |
I liked the article where it says when | lovethatgreen | investorshub | 07/01/2024 4:37:03 PM |
George Sharp posted on X. | splintered sunlight | investorshub | 07/01/2024 4:17:10 PM |
It will all work out. They have | Tiger Money | investorshub | 07/01/2024 4:12:14 PM |
Unfortunately this unforced error listing it at .15 | kevi99 | investorshub | 07/01/2024 4:09:51 PM |
True | Tiger Money | investorshub | 07/01/2024 4:04:43 PM |
.25 minimum | lovethatgreen | investorshub | 07/01/2024 4:04:34 PM |
The reg a will get move to $.25-.50 | Tiger Money | investorshub | 07/01/2024 4:01:11 PM |
Yes that's very nice | lovethatgreen | investorshub | 07/01/2024 3:58:06 PM |
Exactly, which I believe is what will happen. | wrinklesobw | investorshub | 07/01/2024 3:56:52 PM |
Benzinga has 25 million subscribers . | Roofus | investorshub | 07/01/2024 3:53:14 PM |
In the meantime if we get FDA approval, | Rizinup | investorshub | 07/01/2024 3:51:38 PM |
I want this to go to the moon, | splintered sunlight | investorshub | 07/01/2024 3:51:18 PM |
Everything is on schedule | Roofus | investorshub | 07/01/2024 3:48:20 PM |
Okay, now what? | splintered sunlight | investorshub | 07/01/2024 3:47:30 PM |
Benzinga article out | lovethatgreen | investorshub | 07/01/2024 3:45:15 PM |
Buddy I don't care about your trust lmao | lovethatgreen | investorshub | 07/01/2024 3:41:36 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...